The company takes the technical innovation of molecular detection methods as the core driving force, and focuses on the R＆D and industrialization of molecular diagnostic products aiming at ...
In this study, the adhesion-blocking dispirotripiperazine core compound PDSTP was evaluated against SARS-CoV-2 in vitro ... Mini Kit, according to the manufacturer’s protocol. The RNA concentration ...
Methods: Here, we employed a preclinical mouse model to study the adaptive humoral and cellular immune responses to a SARS-CoV-2 receptor binding domain (RBD ... using the non-parametric ...
StockNews.com assumed coverage on shares of OpGen (NASDAQ:OPGN – Free Report) in a research report released on Tuesday. The firm issued a sell rating on the medical research company’s stock. OpGen ...
Opinion
25dOpinion
The first case of COVID-19 was reported in San Diego County on March 9, 2020. Nearly everyone has now been exposed at least once to the SARS-CoV-2 virus. CDC reports over 1.2 million Americans ...
Belfast Live on MSN1d
What it's like to have Covid now as new XEC variant shown to have quicker transmissionThe new XEC variant has been detected in 27 countries across Europe, Asia and North America and it has already been shown to ...
Styczynski and a group of researchers led by former Ph.D. student Megan McSweeney have presented their test in the journal ... and a protein from SARS-CoV-2, the virus that causes COVID-19.
Studies have demonstrated that CRISPR-based diagnostics can detect severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 ... CRISPR-based diagnostic kits could empower frontline health ...
The global coronavirus immunoassay market continues to witness steady growth, reaching USD 3.7 billion in 2021 and is projected to exceed USD 6.9 billion by 2032, expanding at a CAGR of 5.5% during ...
Video Back Videos home Signature collection Essentials collection Artificial Intelligence ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback